Treating Chronic, Intractable Pain with a Miniaturized Spinal Cord Stimulation System: 1-Year Outcomes from the AUS-nPower Study During the COVID-19 Pandemic.

John SalmonDaniel BatesNeels Du ToitPaul VerrillsJames YuMurray G TavernerVahid MohabbatiMatthew GreenGary HeitRobert LevyPeter StaatsShilpa KottalgiJames MakousBruce Mitchell

Published in: Journal of pain research (2024)

There were considerable challenges conducting a clinical study during the COVID-19 pandemic, such as missed study programming visits. Nevertheless, subjects had significant PRO improvements through 1-year. The small size of the implanted device, along with a proprietary waveform, may allow for improved SCS outcomes and a drop in incidence of IPG-pocket pain.

Keyphrases

spinal cord
chronic pain
neuropathic pain
pain management
type diabetes
spinal cord injury
clinical trial
metabolic syndrome
skeletal muscle